Michele W Mak-Fung, MD
Dermatology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 31
- 7 carriers
- Offices
- 7
Offices
7 locations · Csi Medical Group · Sutter Bay Medical Foundation
Plans that list them
31 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mak-Fung’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
31 of 31 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence C53614 · Current
Licensed to practise in California · since 2009 · expires 2028-08-31 · Yale University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$364,581
Medicare paid this office $364,581 for 1,039 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 740 | $89,536 | $80 |
| Destruction of skin growth, 1-14 growths | 409 | $60,137 | $111 |
| Biopsy of related skin growth, first growth | 321 | $33,829 | $84 |
| Destruction of precancer skin growth, 1 growth | 401 | $26,867 | $49 |
| Return visit (30+ min) | 185 | $26,578 | $111 |
See all 21 services
| Short return visit (20+ min) | 740 | $89,536 | $80 |
| Destruction of skin growth, 1-14 growths | 409 | $60,137 | $111 |
| Biopsy of related skin growth, first growth | 321 | $33,829 | $84 |
| Destruction of precancer skin growth, 1 growth | 401 | $26,867 | $49 |
| Return visit (30+ min) | 185 | $26,578 | $111 |
| New patient visit (30+ min) | 197 | $17,838 | $91 |
| Punch biopsy, first skin growth | 77 | $9,590 | $118 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 26 | $9,049 | None |
| Destruction of precancer skin growth, 2-14 growths | 276 | $8,160 | $7 |
| Application of light by qualified health care professional to destroy precancer skin growth | 26 | $7,208 | $233 |
| New patient visit (45+ min) | 38 | $5,699 | $150 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 23 | $4,742 | $176 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 15 | $4,733 | $296 |
| Biopsy of related skin growth, each additional growth | 68 | $3,787 | $52 |
| Short return visit | 71 | $3,626 | $50 |
| Biopsy of ear | 18 | $1,662 | $83 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 11 | $1,541 | $140 |
| Injection into skin growth, 1-7 growths | 21 | $1,523 | $48 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 11 | $1,497 | $125 |
| Tissue fungi or parasites | 33 | $142 | $4 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $31 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 16 | More than 71% of doctors who do this |
| Removal of skin lesions | 1466 | More than 96% of doctors who do this |
| Removal of tissue | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 614 | More than 97% of doctors who do this |
Who their Medicare patients are
1,039 Original Medicare patients in 2024. Average age 76 · Under 65 1% · 85 and older 16% · Women 60% · Also on Medicaid 5% · Health risk score 0.95. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 69% · Diabetes 24% · Coronary heart disease 24% · Chronic kidney disease 16% · Cancer 15% · Atrial fibrillation 15% · Depression 13% · Heart failure 11% · COPD 8% · Stroke 8% · Dementia 5%.
The office billed $792,395, Medicare allowed $488,852 and paid $364,581; for 5,085 services of 46 kinds; $9,090 of it was for drugs given in the office and $355,491 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,039 | 5,085 | 76 | 0.95 | $792,395 | $364,581 |
| 2023 | 1,041 | 4,871 | 76 | 0.94 | $754,968 | $349,391 |
| 2022 | 1,090 | 5,364 | 76 | 0.92 | $836,094 | $383,489 |
| 2021 | 1,155 | 5,605 | 76 | 0.91 | $776,987 | $375,681 |
| 2020 | 929 | 4,346 | 76 | 1.00 | $570,242 | $267,801 |
| 2019 | 943 | 4,689 | 76 | 0.96 | $560,331 | $263,722 |
| 2018 | 813 | 3,759 | 75 | 1.04 | $542,871 | $260,738 |
| 2017 | 884 | 3,777 | 76 | 1.06 | $539,751 | $236,327 |
| 2016 | 740 | 3,453 | 76 | 0.99 | $490,274 | $204,383 |
| 2015 | 796 | 3,983 | 75 | 1.03 | $493,515 | $207,813 |
| 2014 | 841 | 3,762 | 75 | 0.93 | $491,517 | $212,833 |
| 2013 | 765 | 3,319 | 75 | 0.97 | $406,941 | $186,055 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 24 services
| Short return visit (20+ min) | 721 | $84,733 | $77 |
| Destruction of skin growth, 1-14 growths | 369 | $54,326 | $113 |
| Biopsy of related skin growth, first growth | 313 | $36,384 | $95 |
| Return visit (30+ min) | 234 | $33,983 | $116 |
| Destruction of precancer skin growth, 1 growth | 430 | $28,736 | $48 |
| New patient visit (30+ min) | 217 | $19,978 | $92 |
| Punch biopsy, first skin growth | 58 | $7,789 | $130 |
| Destruction of precancer skin growth, 2-14 growths | 290 | $7,387 | $7 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 16 | $6,586 | $412 |
| Biopsy of related skin growth, each additional growth | 98 | $5,809 | $52 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 12 | $4,906 | None |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 12 | $4,787 | $399 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 25 | $4,470 | $179 |
| Application of light by qualified health care professional to destroy precancer skin growth | 12 | $4,054 | $253 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 28 | $3,792 | $131 |
| Short return visit | 48 | $2,610 | $54 |
| New patient visit (45+ min) | 15 | $1,950 | $130 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 12 | $1,825 | $140 |
| Injection into skin growth, 1-7 growths | 22 | $1,683 | $48 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 12 | $1,485 | $124 |
| Biopsy of ear | 18 | $1,439 | $80 |
| Punch biopsy, each additional skin growth | 15 | $920 | $61 |
| New patient visit (15+ min) | 11 | $707 | $64 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 23 | $36 | None |
2022: 19 services
| Short return visit (20+ min) | 834 | $104,012 | $77 |
| Destruction of skin growth, 1-14 growths | 412 | $57,202 | $110 |
| Biopsy of related skin growth, first growth | 364 | $43,059 | $91 |
| Destruction of precancer skin growth, 1 growth | 426 | $30,102 | $48 |
| Return visit (30+ min) | 152 | $21,727 | $110 |
| New patient visit (30+ min) | 238 | $21,233 | $89 |
| Punch biopsy, first skin growth | 68 | $9,064 | $131 |
| Destruction of precancer skin growth, 2-14 growths | 285 | $7,850 | $7 |
| Biopsy of related skin growth, each additional growth | 110 | $7,749 | $53 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 16 | $6,987 | $437 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 38 | $6,346 | $144 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 13 | $5,708 | $408 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 17 | $2,819 | $157 |
| Biopsy of ear | 23 | $1,834 | $76 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 13 | $1,750 | $125 |
| Injection into skin growth, 1-7 growths | 20 | $1,546 | $48 |
| Punch biopsy, each additional skin growth | 15 | $986 | $62 |
| Short return visit | 11 | $557 | $51 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 19 | $38 | None |
2021: 21 services
| Short return visit (20+ min) | 818 | $98,945 | $80 |
| Destruction of skin growth, 1-14 growths | 421 | $59,951 | $113 |
| Biopsy of related skin growth, first growth | 345 | $38,897 | $94 |
| Destruction of precancer skin growth, 1 growth | 426 | $32,064 | $50 |
| Return visit (30+ min) | 203 | $28,150 | $110 |
| New patient visit (30+ min) | 257 | $24,597 | $96 |
| Punch biopsy, first skin growth | 68 | $9,417 | $133 |
| Destruction of precancer skin growth, 2-14 growths | 303 | $9,197 | $7 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 17 | $7,314 | $430 |
| Biopsy of related skin growth, each additional growth | 94 | $6,527 | $55 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 35 | $5,228 | $145 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 12 | $4,189 | None |
| Application of light by qualified health care professional to destroy precancer skin growth | 12 | $3,668 | $262 |
| Injection into skin growth, 1-7 growths | 43 | $3,225 | $45 |
| New patient visit (45+ min) | 22 | $2,575 | $117 |
| Biopsy of ear | 23 | $1,995 | $87 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 14 | $1,790 | $128 |
| Short return visit | 32 | $1,385 | $40 |
| Punch biopsy, each additional skin growth | 14 | $898 | $64 |
| New patient visit (15+ min) | 11 | $467 | $42 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 43 | $76 | None |
2020: 20 services
| Short return visit (20+ min) | 525 | $46,249 | $63 |
| Destruction of skin growth, 1-14 growths | 314 | $41,640 | $108 |
| Return visit (30+ min) | 300 | $35,907 | $94 |
| Biopsy of related skin growth, first growth | 278 | $31,895 | $89 |
| Destruction of precancer skin growth, 1 growth | 325 | $22,127 | $49 |
| New patient visit (30+ min) | 145 | $12,407 | $86 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 18 | $7,868 | $437 |
| Punch biopsy, first skin growth | 55 | $7,411 | $126 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 18 | $7,110 | None |
| Short return visit | 141 | $6,499 | $41 |
| Destruction of precancer skin growth, 2-14 growths | 243 | $6,191 | $6 |
| Biopsy of related skin growth, each additional growth | 85 | $5,931 | $54 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 11 | $4,902 | $408 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 20 | $3,659 | $146 |
| Application of light by qualified health care professional to destroy precancer skin growth | 16 | $3,592 | $180 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 24 | $3,511 | $140 |
| New patient visit (15+ min) | 52 | $3,351 | $64 |
| Injection into skin growth, 1-7 growths | 26 | $1,821 | $49 |
| Biopsy of ear | 20 | $1,668 | $79 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 24 | $42 | None |
2019: 21 services
| Short return visit (20+ min) | 590 | $55,154 | $62 |
| Destruction of skin growth, 1-14 growths | 296 | $39,561 | $105 |
| Destruction of precancer skin growth, 1 growth | 344 | $28,483 | $54 |
| Biopsy of related skin growth, first growth | 219 | $23,673 | $89 |
| New patient visit (30+ min) | 172 | $15,468 | $90 |
| Return visit (30+ min) | 119 | $15,043 | $99 |
| Punch biopsy, first skin growth | 82 | $10,814 | $122 |
| Short return visit | 215 | $10,205 | $40 |
| Destruction of precancer skin growth, 2-14 growths | 266 | $7,943 | $5 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 17 | $6,960 | None |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 15 | $6,759 | $422 |
| New patient visit (15+ min) | 81 | $5,114 | $63 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 29 | $4,515 | $141 |
| Application of light by qualified health care professional to destroy precancer skin growth | 16 | $4,342 | $207 |
| Biopsy of related skin growth, each additional growth | 57 | $4,012 | $53 |
| Destruction of skin growth, 15 or more growths | 12 | $1,902 | $119 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 12 | $1,705 | $131 |
| Injection into skin growth, 1-7 growths | 22 | $1,508 | $49 |
| Biopsy of ear | 19 | $1,487 | $78 |
| Punch biopsy, each additional skin growth | 13 | $751 | $58 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $36 | None |
2018: 17 services
| Short return visit (20+ min) | 508 | $54,429 | $67 |
| Biopsy of single growth of skin and/or tissue | 322 | $41,559 | $103 |
| Destruction of skin growth, 1-14 growths | 205 | $29,432 | $113 |
| Destruction of precancer skin growth, 1 growth | 279 | $23,719 | $57 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 23 | $22,508 | $313 |
| New patient visit (30+ min) | 179 | $17,135 | $96 |
| High dose rate electronic brachytherapy, external | 23 | $11,563 | $134 |
| Return visit (30+ min) | 73 | $10,509 | $100 |
| Short return visit | 160 | $8,148 | $39 |
| Destruction of precancer skin growth, 2-14 growths | 202 | $4,357 | $5 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 26 | $4,112 | $152 |
| New patient visit (15+ min) | 62 | $3,621 | $58 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 16 | $2,994 | $176 |
| Biopsy of each additional growth of skin and/or tissue | 71 | $2,952 | $32 |
| Biopsy of ear | 19 | $1,641 | $86 |
| Injection into skin growth, 1-7 growths | 11 | $648 | $43 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $21 | None |
2017: 17 services
| Short return visit (20+ min) | 581 | $53,740 | $60 |
| Biopsy of single growth of skin and/or tissue | 329 | $37,266 | $90 |
| Destruction of skin growth, 1-14 growths | 211 | $27,221 | $105 |
| Destruction of precancer skin growth, 1 growth | 310 | $22,008 | $50 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 29 | $21,391 | $289 |
| New patient visit (30+ min) | 171 | $14,100 | $82 |
| High dose rate electronic brachytherapy, external | 29 | $10,790 | $125 |
| Return visit (30+ min) | 62 | $7,498 | $88 |
| Short return visit | 153 | $6,526 | $38 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 11 | $4,487 | $408 |
| New patient visit (15+ min) | 68 | $4,304 | $63 |
| Destruction of precancer skin growth, 2-14 growths | 213 | $4,013 | $5 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 27 | $3,940 | $131 |
| Biopsy of each additional growth of skin and/or tissue | 106 | $3,898 | $30 |
| Biopsy of ear | 17 | $1,436 | $72 |
| Injection into skin growth, 1-7 growths | 14 | $760 | $40 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $27 | None |
2016: 15 services
| Short return visit (20+ min) | 515 | $56,255 | $60 |
| Biopsy of single growth of skin and/or tissue | 308 | $36,007 | $89 |
| Destruction of skin growth, 1-14 growths | 185 | $22,286 | $102 |
| Destruction of precancer skin growth, 1 growth | 300 | $22,043 | $49 |
| New patient visit (30+ min) | 159 | $12,976 | $82 |
| Return visit (30+ min) | 52 | $6,538 | $88 |
| Short return visit | 119 | $5,727 | $39 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 33 | $4,548 | $130 |
| Biopsy of each additional growth of skin and/or tissue | 93 | $3,768 | $30 |
| Destruction of precancer skin growth, 2-14 growths | 175 | $2,959 | $5 |
| New patient visit (15+ min) | 37 | $1,936 | $52 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 13 | $1,837 | $131 |
| Biopsy of ear | 17 | $1,535 | $85 |
| Injection into skin growth, 1-7 growths | 12 | $771 | $43 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $25 | None |
2015: 15 services
| Short return visit (20+ min) | 578 | $58,451 | $60 |
| Biopsy of single growth of skin and/or tissue | 302 | $35,054 | $90 |
| Destruction of skin growth, 1-14 growths | 192 | $24,388 | $101 |
| Destruction of precancer skin growth, 1 growth | 319 | $23,786 | $49 |
| New patient visit (30+ min) | 168 | $14,383 | $86 |
| Short return visit | 153 | $7,264 | $38 |
| Return visit (30+ min) | 50 | $6,378 | $86 |
| Destruction of precancer skin growth, 2-14 growths | 195 | $4,106 | $5 |
| Biopsy of each additional growth of skin and/or tissue | 100 | $4,021 | $29 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 21 | $3,124 | $136 |
| New patient visit (15+ min) | 32 | $1,590 | $50 |
| Injection into skin growth, 1-7 growths | 18 | $1,334 | $40 |
| Biopsy of ear | 16 | $1,272 | $71 |
| Tissue fungi or parasites | 25 | $154 | $6 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $39 | None |
2014: 18 services
| Short return visit (20+ min) | 581 | $53,978 | $60 |
| Biopsy of single growth of skin and/or tissue | 347 | $39,577 | $90 |
| Destruction of precancer skin growth, 1 growth | 299 | $25,971 | $56 |
| Destruction of skin growth, 1-14 growths | 162 | $18,714 | $100 |
| New patient visit (30+ min) | 190 | $15,549 | $82 |
| Short return visit | 206 | $9,708 | $37 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 24 | $7,014 | $281 |
| Destruction of precancer skin growth, 2-14 growths | 193 | $6,970 | $10 |
| Return visit (30+ min) | 37 | $4,828 | $88 |
| Biopsy of each additional growth of skin and/or tissue | 84 | $3,400 | $30 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 18 | $2,761 | $131 |
| New patient visit (15+ min) | 46 | $2,632 | $57 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 14 | $1,886 | $126 |
| Application of light to destroy precancer skin growth | 11 | $1,697 | $121 |
| Biopsy of ear | 12 | $917 | $71 |
| Injection into skin growth, 1-7 growths | 14 | $699 | $33 |
| Tissue fungi or parasites | 54 | $371 | $6 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $31 | None |
2013: 16 services
| Short return visit (20+ min) | 496 | $47,797 | $61 |
| Biopsy of single growth of skin and/or tissue | 332 | $37,418 | $92 |
| Destruction of precancer skin growth, 1 growth | 265 | $24,548 | $63 |
| Destruction of skin growth, 1-14 growths | 141 | $18,663 | $104 |
| New patient visit (30+ min) | 169 | $15,265 | $90 |
| Short return visit | 215 | $10,483 | $38 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 13 | $4,118 | $294 |
| Destruction of precancer skin growth, 2-14 growths | 171 | $3,967 | $6 |
| Biopsy of each additional growth of skin and/or tissue | 87 | $3,291 | $30 |
| New patient visit (15+ min) | 51 | $3,200 | $63 |
| Return visit (30+ min) | 21 | $2,880 | $96 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 18 | $2,515 | $120 |
| Biopsy of ear | 18 | $1,716 | $82 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 11 | $1,462 | $133 |
| Injection into skin growth, 1-7 growths | 11 | $823 | $43 |
| Tissue fungi or parasites | 53 | $323 | $6 |
Drugs they prescribed that Part D paid
$535,091
Pharmacies billed $535,091 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,445) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
1,314 generic and 131 brand-name prescriptions · $535,091 in drug cost · 118 antibiotic prescriptions to 97 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Taltz | 21 | $149,807 | $7,134 |
| Dupixent | 28 | $105,993 | $3,785 |
| Fluorouracil | 103 | $7,698 | $75 |
| Clobetasol Propionate | 123 | $6,064 | $49 |
| Acitretin | 30 | $5,506 | $184 |
See all 31 drugs
| Taltz | 21 | $149,807 | $7,134 |
| Dupixent | 28 | $105,993 | $3,785 |
| Fluorouracil | 103 | $7,698 | $75 |
| Clobetasol Propionate | 123 | $6,064 | $49 |
| Acitretin | 30 | $5,506 | $184 |
| Calcipotriene | 31 | $4,295 | $139 |
| Tacrolimus | 32 | $2,383 | $74 |
| Metronidazole | 35 | $2,129 | $61 |
| Betamethasone Diprop Augmented | 33 | $1,446 | $44 |
| Ketoconazole | 117 | $1,315 | $11 |
| Ciclopirox | 66 | $1,295 | $20 |
| Triamcinolone Acetonide | 194 | $1,174 | $6 |
| Doxycycline Hyclate | 46 | $1,149 | $25 |
| Betamethasone Dipropionate | 34 | $886 | $26 |
| Clindamycin Phosphate | 34 | $739 | $22 |
| Valacyclovir | 18 | $723 | $40 |
| Methotrexate | 29 | $610 | $21 |
| Fluocinonide | 18 | $408 | $23 |
| Mometasone Furoate | 33 | $369 | $11 |
| Cephalexin | 75 | $351 | $5 |
| Betamethasone Valerate | 11 | $315 | $29 |
| Mupirocin | 44 | $287 | $7 |
| Gabapentin | 19 | $263 | $14 |
| Imiquimod | 12 | $225 | $19 |
| Ciclopirox | 11 | $217 | $20 |
| Fluconazole | 15 | $207 | $14 |
| Minoxidil | 22 | $185 | $8 |
| Finasteride | 15 | $174 | $12 |
| Hydroxyzine | 19 | $110 | $6 |
| Prednisone | 28 | $99 | $4 |
| Terbinafine | 13 | $88 | $7 |
Year by year
| 2024 | 1,445 | 567 | 0% (0) | 9% | $535,091 |
| 2023 | 1,551 | 585 | 0% (0) | 9% | $616,711 |
| 2022 | 1,394 | 586 | 0% (0) | 6% | $510,145 |
| 2021 | 1,289 | 553 | 0% (0) | 8% | $491,378 |
| 2020 | 1,251 | 510 | 0% (0) | 7% | $372,319 |
| 2019 | 1,205 | 501 | None | None | $149,840 |
| 2018 | 1,122 | 491 | 0% (0) | None | $162,090 |
| 2017 | 1,070 | 479 | 0% (0) | 12% | $131,360 |
| 2016 | 1,019 | 416 | None | 18% | $147,220 |
| 2015 | 782 | 345 | 0% (0) | 21% | $107,745 |
| 2014 | 797 | 344 | None | None | $93,232 |
| 2013 | 704 | 284 | 0% (0) | None | $66,116 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 31 drugs
| Taltz | 30 | $219,512 | $7,317 |
| Dupixent | 19 | $72,354 | $3,808 |
| Dupixent | 11 | $61,906 | $5,628 |
| Fluorouracil | 135 | $10,931 | $81 |
| Clobetasol Propionate | 133 | $8,611 | $65 |
| Acitretin | 18 | $6,842 | $380 |
| Calcipotriene | 28 | $6,209 | $222 |
| Pimecrolimus | 13 | $4,489 | $345 |
| Metronidazole | 47 | $3,994 | $85 |
| Tacrolimus | 15 | $2,249 | $150 |
| Doxycycline Hyclate | 44 | $2,223 | $51 |
| Ciclopirox | 74 | $2,134 | $29 |
| Betamethasone Diprop Augmented | 31 | $1,430 | $46 |
| Ketoconazole | 91 | $1,393 | $15 |
| Triamcinolone Acetonide | 234 | $1,336 | $6 |
| Betamethasone Dipropionate | 31 | $1,189 | $38 |
| Ciclopirox | 18 | $834 | $46 |
| Valacyclovir | 23 | $767 | $33 |
| Mupirocin | 63 | $718 | $11 |
| Mometasone Furoate | 46 | $692 | $15 |
| Finasteride | 31 | $489 | $16 |
| Cephalexin | 79 | $478 | $6 |
| Betamethasone Valerate | 17 | $439 | $26 |
| Fluocinonide | 13 | $414 | $32 |
| Hydroxyzine | 24 | $405 | $17 |
| Clindamycin Phosphate | 14 | $364 | $26 |
| Methotrexate | 18 | $324 | $18 |
| Minoxidil | 21 | $210 | $10 |
| Hydrocortisone | 32 | $184 | $6 |
| Prednisone | 32 | $160 | $5 |
| Gabapentin | 22 | $149 | $7 |
2022: 28 drugs
| Taltz | 12 | $146,835 | $12,236 |
| Fluorouracil | 146 | $14,601 | $100 |
| Clobetasol Propionate | 132 | $7,572 | $57 |
| Calcipotriene | 27 | $4,388 | $163 |
| Tacrolimus | 20 | $4,298 | $215 |
| Metronidazole | 44 | $3,470 | $79 |
| Doxycycline Hyclate | 60 | $2,381 | $40 |
| Betamethasone Diprop Augmented | 54 | $2,082 | $39 |
| Ketoconazole | 89 | $1,742 | $20 |
| Triamcinolone Acetonide | 180 | $1,302 | $7 |
| Ciclopirox | 46 | $1,196 | $26 |
| Betamethasone Dipropionate | 34 | $1,125 | $33 |
| Methotrexate | 32 | $1,082 | $34 |
| Mometasone Furoate | 59 | $1,050 | $18 |
| Imiquimod | 19 | $1,045 | $55 |
| Valacyclovir | 22 | $870 | $40 |
| Fluocinonide | 16 | $775 | $48 |
| Clindamycin Phosphate | 17 | $439 | $26 |
| Mupirocin | 44 | $439 | $10 |
| Cephalexin | 69 | $401 | $6 |
| Ciclopirox | 18 | $379 | $21 |
| Finasteride | 21 | $365 | $17 |
| Prednisone | 36 | $199 | $6 |
| Gabapentin | 12 | $181 | $15 |
| Hydroxyzine | 11 | $113 | $10 |
| Hydrocortisone | 17 | $102 | $6 |
| Fluconazole | 14 | $102 | $7 |
| Minoxidil | 11 | $97 | $9 |
2021: 30 drugs
| Taltz | 18 | $134,067 | $7,448 |
| Dupixent | 15 | $60,414 | $4,028 |
| Fluorouracil | 157 | $15,727 | $100 |
| Clobetasol Propionate | 103 | $5,748 | $56 |
| Acitretin | 18 | $4,143 | $230 |
| Metronidazole | 50 | $4,009 | $80 |
| Tacrolimus | 20 | $3,985 | $199 |
| Betamethasone Diprop Augmented | 44 | $2,903 | $66 |
| Ketoconazole | 103 | $2,210 | $21 |
| Calcipotriene | 16 | $1,576 | $99 |
| Doxycycline Hyclate | 31 | $1,330 | $43 |
| Fluocinonide | 19 | $1,220 | $64 |
| Imiquimod | 17 | $898 | $53 |
| Triamcinolone Acetonide | 136 | $881 | $6 |
| Mometasone Furoate | 51 | $841 | $16 |
| Methotrexate | 15 | $750 | $50 |
| Valacyclovir | 18 | $711 | $39 |
| Ciclopirox | 26 | $672 | $26 |
| Betamethasone Dipropionate | 15 | $602 | $40 |
| Ciclopirox | 21 | $571 | $27 |
| Fluconazole | 41 | $436 | $11 |
| Mupirocin | 37 | $345 | $9 |
| Clindamycin Phosphate | 14 | $330 | $24 |
| Gabapentin | 24 | $285 | $12 |
| Cephalexin | 61 | $273 | $4 |
| Ammonium Lactate | 13 | $272 | $21 |
| Finasteride | 26 | $265 | $10 |
| Prednisone | 31 | $190 | $6 |
| Terbinafine | 16 | $165 | $10 |
| Hydrocortisone | 13 | $87 | $7 |
2020: 27 drugs
| Taltz | 11 | $63,035 | $5,730 |
| Dupixent | 19 | $61,984 | $3,262 |
| Fluorouracil | 124 | $12,556 | $101 |
| Acitretin | 20 | $6,992 | $350 |
| Calcipotriene | 35 | $5,445 | $156 |
| Metronidazole | 63 | $5,288 | $84 |
| Clobetasol Propionate | 84 | $5,284 | $63 |
| Pimecrolimus | 12 | $3,273 | $273 |
| Betamethasone Diprop Augmented | 73 | $2,682 | $37 |
| Fluocinonide | 39 | $1,852 | $47 |
| Ketoconazole | 74 | $1,496 | $20 |
| Halobetasol Propionate | 11 | $1,435 | $130 |
| Ciclopirox | 48 | $1,243 | $26 |
| Ciclopirox | 35 | $1,206 | $34 |
| Doxycycline Hyclate | 36 | $1,120 | $31 |
| Imiquimod | 13 | $1,043 | $80 |
| Triamcinolone Acetonide | 132 | $945 | $7 |
| Mometasone Furoate | 49 | $827 | $17 |
| Methotrexate | 18 | $771 | $43 |
| Valacyclovir | 11 | $537 | $49 |
| Cephalexin | 88 | $446 | $5 |
| Mupirocin | 28 | $342 | $12 |
| Clindamycin Phosphate | 13 | $341 | $26 |
| Prednisone | 41 | $248 | $6 |
| Finasteride | 28 | $245 | $9 |
| Hydrocortisone | 22 | $123 | $6 |
| Gabapentin | 11 | $69 | $6 |
2019: 25 drugs
| Taltz | 11 | $61,094 | $5,554 |
| Fluorouracil | 151 | $15,964 | $106 |
| Clobetasol Propionate | 72 | $4,862 | $68 |
| Pimecrolimus | 12 | $4,681 | $390 |
| Calcipotriene | 24 | $4,550 | $190 |
| Metronidazole | 45 | $3,985 | $89 |
| Imiquimod | 22 | $2,021 | $92 |
| Doxycycline Hyclate | 44 | $1,965 | $45 |
| Ketoconazole | 96 | $1,642 | $17 |
| Ciclopirox | 46 | $1,544 | $34 |
| Mometasone Furoate | 52 | $1,517 | $29 |
| Betamethasone Diprop Augmented | 35 | $1,270 | $36 |
| Triamcinolone Acetonide | 165 | $1,132 | $7 |
| Fluocinonide | 21 | $1,048 | $50 |
| Halobetasol Propionate | 14 | $991 | $71 |
| Methotrexate | 21 | $981 | $47 |
| Valacyclovir | 17 | $758 | $45 |
| Ciclopirox | 23 | $742 | $32 |
| Clindamycin Phosphate | 12 | $554 | $46 |
| Cephalexin | 66 | $416 | $6 |
| Hydroxyzine | 16 | $415 | $26 |
| Mupirocin | 28 | $260 | $9 |
| Prednisone | 40 | $214 | $5 |
| Hydrocortisone | 25 | $206 | $8 |
| Gabapentin | 14 | $169 | $12 |
2018: 22 drugs
| Fluorouracil | 109 | $11,914 | $109 |
| Clobetasol Propionate | 93 | $8,863 | $95 |
| Doxycycline Hyclate | 50 | $3,208 | $64 |
| Calcipotriene | 15 | $2,862 | $191 |
| Betamethasone Diprop Augmented | 51 | $2,649 | $52 |
| Fluocinonide | 33 | $1,541 | $47 |
| Ciclopirox | 43 | $1,503 | $35 |
| Ketoconazole | 72 | $1,398 | $19 |
| Mometasone Furoate | 61 | $1,317 | $22 |
| Imiquimod | 27 | $1,246 | $46 |
| Clindamycin Phosphate | 24 | $1,169 | $49 |
| Metronidazole | 14 | $1,085 | $78 |
| Ciclopirox | 32 | $1,052 | $33 |
| Triamcinolone Acetonide | 127 | $921 | $7 |
| Permethrin | 13 | $913 | $70 |
| Betamethasone Dipropionate | 17 | $864 | $51 |
| Valacyclovir | 12 | $341 | $28 |
| Cephalexin | 68 | $325 | $5 |
| Prednisone | 58 | $319 | $6 |
| Hydrocortisone | 23 | $177 | $8 |
| Hydroxyzine | 17 | $152 | $9 |
| Mupirocin | 15 | $122 | $8 |
2017: 23 drugs
| Clobetasol Propionate | 119 | $16,826 | $141 |
| Fluorouracil | 105 | $11,809 | $112 |
| Finacea | 12 | $3,588 | $299 |
| Calcipotriene | 14 | $3,151 | $225 |
| Imiquimod | 35 | $2,849 | $81 |
| Tretinoin | 15 | $2,610 | $174 |
| Doxycycline Hyclate | 60 | $2,389 | $40 |
| Halobetasol Propionate | 17 | $1,929 | $113 |
| Desoximetasone | 15 | $1,830 | $122 |
| Ciclopirox | 48 | $1,719 | $36 |
| Ketoconazole | 78 | $1,614 | $21 |
| Desonide | 25 | $1,417 | $57 |
| Metronidazole | 14 | $1,342 | $96 |
| Mometasone Furoate | 56 | $1,310 | $23 |
| Fluocinonide | 18 | $1,009 | $56 |
| Triamcinolone Acetonide | 94 | $826 | $9 |
| Clindamycin Phosphate | 15 | $739 | $49 |
| Ciclopirox | 16 | $676 | $42 |
| Valacyclovir | 18 | $451 | $25 |
| Cephalexin | 69 | $404 | $6 |
| Prednisone | 56 | $295 | $5 |
| Mupirocin | 35 | $293 | $8 |
| Hydrocortisone | 18 | $115 | $6 |
2016: 19 drugs
| Clobetasol Propionate | 131 | $21,952 | $168 |
| Fluorouracil | 118 | $16,945 | $144 |
| Calcipotriene | 30 | $12,085 | $403 |
| Doxycycline Hyclate | 47 | $3,399 | $72 |
| Imiquimod | 41 | $2,696 | $66 |
| Ciclopirox | 45 | $2,236 | $50 |
| Metronidazole | 22 | $2,096 | $95 |
| Desonide | 28 | $2,042 | $73 |
| Ketoconazole | 79 | $2,028 | $26 |
| Halobetasol Propionate | 16 | $1,729 | $108 |
| Triamcinolone Acetonide | 124 | $1,343 | $11 |
| Permethrin | 11 | $1,136 | $103 |
| Mometasone Furoate | 43 | $1,074 | $25 |
| Fluocinonide | 14 | $784 | $56 |
| Methotrexate | 12 | $456 | $38 |
| Valacyclovir | 12 | $370 | $31 |
| Mupirocin | 33 | $322 | $10 |
| Cephalexin | 43 | $243 | $6 |
| Prednisone | 41 | $208 | $5 |
2015: 18 drugs
| Clobetasol Propionate | 102 | $17,203 | $169 |
| Fluorouracil | 80 | $12,593 | $157 |
| Calcipotriene | 26 | $6,183 | $238 |
| Desonide | 59 | $5,274 | $89 |
| Imiquimod | 22 | $3,628 | $165 |
| Metronidazole | 20 | $2,546 | $127 |
| Ciclopirox | 42 | $1,720 | $41 |
| Triamcinolone Acetonide | 101 | $1,082 | $11 |
| Doxycycline Hyclate | 12 | $1,042 | $87 |
| Ciclopirox | 16 | $974 | $61 |
| Ketoconazole | 46 | $862 | $19 |
| Valacyclovir | 13 | $558 | $43 |
| Fluocinonide | 11 | $524 | $48 |
| Mometasone Furoate | 25 | $428 | $17 |
| Ammonium Lactate | 11 | $259 | $24 |
| Cephalexin | 35 | $157 | $4 |
| Mupirocin | 16 | $122 | $8 |
| Prednisone | 18 | $95 | $5 |
2014: 16 drugs
| Fluorouracil | 90 | $15,655 | $174 |
| Desonide | 77 | $8,899 | $116 |
| Imiquimod | 29 | $7,246 | $250 |
| Clobetasol Propionate | 104 | $6,874 | $66 |
| Desoximetasone | 13 | $2,656 | $204 |
| Metronidazole | 17 | $2,306 | $136 |
| Ciclopirox | 41 | $1,713 | $42 |
| Ketoconazole | 69 | $1,419 | $21 |
| Permethrin | 13 | $1,137 | $87 |
| Triamcinolone Acetonide | 82 | $791 | $10 |
| Mometasone Furoate | 24 | $350 | $15 |
| Ammonium Lactate | 16 | $306 | $19 |
| Cephalexin | 46 | $215 | $5 |
| Mupirocin | 19 | $211 | $11 |
| Hydroxyzine | 12 | $137 | $11 |
| Prednisone | 16 | $68 | $4 |
2013: 16 drugs
| Fluorouracil | 92 | $17,550 | $191 |
| Imiquimod | 16 | $6,807 | $425 |
| Desonide | 46 | $6,527 | $142 |
| Clobetasol Propionate | 68 | $3,670 | $54 |
| Desoximetasone | 19 | $3,546 | $187 |
| Doxycycline Hyclate | 20 | $3,006 | $150 |
| Metronidazole | 15 | $2,083 | $139 |
| Halobetasol Propionate | 26 | $1,946 | $75 |
| Ciclopirox | 31 | $1,250 | $40 |
| Ketoconazole | 57 | $989 | $17 |
| Clindamycin Phosphate | 11 | $744 | $68 |
| Mometasone Furoate | 26 | $629 | $24 |
| Triamcinolone Acetonide | 55 | $626 | $11 |
| Mupirocin | 22 | $339 | $15 |
| Cephalexin | 44 | $233 | $5 |
| Prednisone | 22 | $114 | $5 |
Money from drug and device companies
$1,825 in 2025
| 2025 | 18 | 88 | None | $1,825 |
| 2024 | 15 | 88 | None | $1,697 |
| 2023 | 13 | 74 | None | $1,191 |
| 2022 | 10 | 42 | None | $728 |
| 2021 | 11 | 50 | None | $724 |
| 2020 | 11 | 65 | None | $692 |
| 2019 | 11 | 44 | None | $743 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Skyrizi | $280 | 19 payments
|
| Regeneron Healthcare Solutions | Dupixent | $256 | 11 payments
|
| Genzyme | Dupixent | $202 | 7 payments
|
| Ucb | Bimzelx | $161 | 4 payments
|
| Arcutis Biotherapeutics | Zoryve | $159 | 10 payments
|
| Lilly USA | Taltz | $98 | 5 payments
|
See all 88 published payments
| LEO Pharma | Meals · 2025-12-10 | Adbry | $30 |
| LEO Pharma | Meals · 2025-12-10 | Adbry | $30 |
| Ucb | Meals · 2025-12-09 | Bimzelx | $20 |
| Abbvie | Meals · 2025-12-06 | Rinvoq | $25 |
| Organon | Meals · 2025-12-05 | None | $1 |
| Genzyme | Meals · 2025-11-17 | Dupixent | $10 |
| Regeneron Healthcare Solutions | Meals · 2025-11-11 | Libtayo | $29 |
| Arcutis Biotherapeutics | Meals · 2025-11-07 | Zoryve | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-11-05 | Dupixent | $0 |
| Regeneron Healthcare Solutions | Meals · 2025-11-05 | Dupixent | $8 |
| Amgen | Meals · 2025-11-05 | Otezla | $25 |
| Organon | Meals · 2025-11-03 | None | $9 |
| Regeneron Healthcare Solutions | Meals · 2025-10-29 | Libtayo | $17 |
| Organon | Meals · 2025-10-23 | None | $13 |
| Regeneron Healthcare Solutions | Meals · 2025-10-20 | Dupixent | $17 |
| Organon | Meals · 2025-10-20 | Nexplanon | $12 |
| Abbvie | Meals · 2025-10-16 | Skyrizi | $6 |
| Organon | Meals · 2025-10-16 | Nexplanon | $3 |
| Lilly USA | Meals · 2025-10-14 | Taltz | $16 |
| Genzyme | Meals · 2025-10-09 | Dupixent | $125 |
| Regeneron Healthcare Solutions | Meals · 2025-10-08 | Dupixent | $21 |
| Amgen | Meals · 2025-10-08 | Otezla | $20 |
| Sun Pharmaceutical Industries | Meals · 2025-10-01 | Ilumya | $17 |
| Abbvie | Meals · 2025-09-30 | Skyrizi | $7 |
| Organon | Meals · 2025-09-29 | None | $9 |
| Incyte | Meals · 2025-09-27 | Opzelura | $15 |
| Novartis Pharmaceuticals | Meals · 2025-09-24 | Cosentyx | $18 |
| Regeneron Healthcare Solutions | Education · 2025-09-23 | Dupixent | $74 |
| Abbvie | Meals · 2025-09-22 | Skyrizi | $26 |
| Ucb | Meals · 2025-09-22 | Bimzelx | $18 |
| Arcutis Biotherapeutics | Meals · 2025-09-15 | Zoryve | $9 |
| Lilly USA | Meals · 2025-09-04 | Taltz | $20 |
| Ucb | Meals · 2025-09-04 | Bimzelx | $108 |
| Regeneron Healthcare Solutions | Meals · 2025-08-29 | Dupixent | $26 |
| Lilly USA | Meals · 2025-08-20 | Taltz | $14 |
| Abbvie | Meals · 2025-08-12 | Skyrizi | $19 |
| Novartis Pharmaceuticals | Meals · 2025-08-08 | Cosentyx | $18 |
| Arcutis Biotherapeutics | Meals · 2025-08-06 | Zoryve | $22 |
| Genzyme | Meals · 2025-07-22 | Dupixent | $9 |
| Blueprint Medicines | Meals · 2025-07-17 | Ayvakit | $30 |
| Genzyme | Meals · 2025-07-16 | Dupixent | $16 |
| Lilly USA | Meals · 2025-07-15 | Taltz | $30 |
| Abbvie | Meals · 2025-07-09 | Skyrizi | $8 |
| Arcutis Biotherapeutics | Meals · 2025-06-30 | Zoryve | $12 |
| Abbvie | Meals · 2025-06-26 | Skyrizi | $7 |
| Botanix SB | Meals · 2025-06-26 | Sofdra | $18 |
| Novartis Pharmaceuticals | Meals · 2025-06-17 | Cosentyx | $27 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-12 | Sotyktu | $20 |
| Arcutis Biotherapeutics | Meals · 2025-06-12 | Zoryve | $10 |
| Abbvie | Meals · 2025-05-30 | Rinvoq | $18 |
| Novartis Pharmaceuticals | Meals · 2025-05-16 | Cosentyx | $17 |
| Abbvie | Meals · 2025-05-15 | Skyrizi | $14 |
| Genzyme | Meals · 2025-05-15 | Dupixent | $9 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-08 | Sotyktu | $17 |
| Abbvie | Meals · 2025-05-08 | Skyrizi | $16 |
| Genzyme | Meals · 2025-05-08 | Dupixent | $26 |
| Arcutis Biotherapeutics | Meals · 2025-05-07 | Zoryve | $9 |
| Regeneron Healthcare Solutions | Meals · 2025-05-06 | Dupixent | $31 |
| Amgen | Meals · 2025-05-01 | Otezla | $14 |
| Abbvie | Meals · 2025-04-22 | Skyrizi | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-04-22 | Dupixent | $19 |
| Biofrontera | Meals · 2025-04-14 | None | $28 |
| Janssen Biotech | Meals · 2025-04-09 | Tremfya | $23 |
| Arcutis Biotherapeutics | Meals · 2025-04-03 | Zoryve | $21 |
| Incyte | Meals · 2025-03-27 | Opzelura | $22 |
| Abbvie | Meals · 2025-03-26 | Skyrizi | $13 |
| Incyte | Meals · 2025-03-26 | Opzelura | $24 |
| Sun Pharmaceutical Industries | Meals · 2025-03-26 | Winlevi | $21 |
| Abbvie | Meals · 2025-03-20 | Skyrizi | $19 |
| Arcutis Biotherapeutics | Meals · 2025-03-20 | Zoryve | $23 |
| Abbvie | Meals · 2025-03-13 | Skyrizi | $15 |
| Abbvie | Education · 2025-03-13 | Skyrizi | $10 |
| Regeneron Healthcare Solutions | Meals · 2025-03-12 | Dupixent | $15 |
| Amgen | Meals · 2025-03-07 | Otezla | $17 |
| Abbvie | Meals · 2025-03-06 | Skyrizi | $11 |
| Arcutis Biotherapeutics | Meals · 2025-03-06 | Zoryve | $10 |
| Ucb | Meals · 2025-02-21 | Bimzelx | $14 |
| Lilly USA | Meals · 2025-02-13 | Taltz | $18 |
| Janssen Biotech | Meals · 2025-02-12 | Tremfya | $22 |
| Arcutis Biotherapeutics | Meals · 2025-02-10 | Zoryve | $21 |
| Incyte | Meals · 2025-02-06 | Opzelura | $25 |
| Genzyme | Meals · 2025-02-05 | Dupixent | $7 |
| Organon | Meals · 2025-02-05 | Vtama | $9 |
| Janssen Biotech | Meals · 2025-01-28 | Tremfya | $22 |
| Abbvie | Meals · 2025-01-28 | Skyrizi | $25 |
| Abbvie | Meals · 2025-01-21 | Skyrizi | $16 |
| Abbvie | Meals · 2025-01-17 | Skyrizi | $8 |
| Sanofi-Aventis U.S. | Education · 2025-01-07 | Dupixent | $95 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,697
| Abbvie | Skyrizi | $433 | 23 payments
|
| Amgen | Otezla | $172 | 8 payments
|
| Incyte | Opzelura | $171 | 9 payments
|
| Arcutis Biotherapeutics | Zoryve | $164 | 11 payments
|
| Regeneron Healthcare Solutions | Dupixent | $158 | 9 payments
|
| Genzyme | Dupixent | $150 | 6 payments
|
| Lilly USA | Taltz | $80 | 4 payments
|
| Janssen Biotech | Tremfya | $76 | 4 payments
|
| Novartis Pharmaceuticals | Cosentyx | $69 | 3 payments
|
| LEO Pharma | Adbry | $51 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $48 | 2 payments
|
| Galderma Laboratories L.P. | Aklief | $39 | 2 payments
|
| Ucb | Bimzelx | $38 | 2 payments
|
| Sun Pharmaceutical Industries | Ilumya | $32 | 2 payments
|
| Dermavant Sciences | Vtama | $16 | 1 payment
|
2023: $1,191
| Abbvie | Skyrizi | $335 | 29 payments
|
| Janssen Biotech | Tremfya | $196 | 13 payments
|
| Genzyme | Dupixent | $185 | 9 payments
|
| Novartis Pharmaceuticals | Cosentyx | $87 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $77 | 4 payments
|
| Incyte | Opzelura | $76 | 3 payments
|
| Dermavant Sciences | Vtama | $54 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Siliq | $49 | 3 payments
|
| Amgen | Otezla | $38 | 2 payments
|
| Sun Pharmaceutical Industries | Winlevi | $32 | 2 payments
|
| Pfizer | Eucrisa | $26 | 1 payment
|
| Almirall | Klisyri | $21 | 1 payment
|
| Arcutis Biotherapeutics | None | $13 | 1 payment
|
2022: $728
| Abbvie | Skyrizi | $296 | 23 payments
|
| Regeneron Healthcare Solutions | Dupixent | $147 | 4 payments
|
| Genzyme | Dupixent | $86 | 3 payments
|
| Novartis Pharmaceuticals | Cosentyx | $63 | 4 payments
|
| Ortho Dermatologics a division of Bausch Health US | Siliq | $38 | 2 payments
|
| Pfizer | Cibinqo | $26 | 1 payment
|
| Journey Medical | Qbrexza | $25 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $18 | 1 payment
|
| EPI Health | Cloderm | $16 | 1 payment
|
| Incyte | Opzelura | $14 | 1 payment
|
2021: $724
| AbbVie | Skyrizi | $225 | 22 payments
|
| Janssen Biotech | Remicade | $119 | 8 payments
|
| Genzyme | Dupixent | $111 | 5 payments
|
| Pfizer | Eucrisa | $79 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $61 | 4 payments
|
| LEO Pharma | Enstilar | $32 | 2 payments
|
| VYNE Pharmaceuticals | Amzeeq | $24 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $19 | 1 payment
|
| Sun Pharmaceutical Industries | Blu-U | $19 | 1 payment
|
| Sanofi-Aventis U.S. | Dupixent | $19 | 1 payment
|
| Lilly USA | Taltz | $16 | 1 payment
|
2020: $692
| Janssen Biotech | Tremfya | $207 | 12 payments
|
| LEO Pharma | Enstilar | $206 | 39 payments
|
| Pfizer | Eucrisa | $70 | 4 payments
|
| VYNE Pharmaceuticals | Amzeeq | $45 | 2 payments
|
| AbbVie | Humira | $36 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $23 | 1 payment
|
| Sanofi-Aventis U.S. | Dupixent | $23 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $21 | 1 payment
|
| Sun Pharmaceutical Industries | Absorica Ld | $21 | 1 payment
|
| Dermira | Qbrexza | $20 | 1 payment
|
| Genzyme | Dupixent | $19 | 1 payment
|
2019: $743
| Genentech USA | Erivedge | $144 | 1 payment
|
| Celgene | Otezla | $139 | 6 payments
|
| Novartis Pharmaceuticals | Cosentyx | $137 | 14 payments
|
| Janssen Biotech | Tremfya | $126 | 11 payments
|
| Ucb | Cimzia | $59 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $32 | 2 payments
|
| Pfizer | Eucrisa | $31 | 2 payments
|
| AbbVie | Humira | $23 | 1 payment
|
| Sun Pharmaceutical Industries | Ilumya | $21 | 1 payment
|
| Biofrontera | Ameluz | $20 | 1 payment
|
| LEO Pharma | Enstilar | $12 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1174661086
- Licence
- CA C53614California C53614: Current · expires 2028-08-31
- Trained
- Yale University School of Medicine, 2004
- Group
- Csi Medical Group · Sutter Bay Medical Foundation
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2007-02-02
- NPI last updated
- 2026-01-13
- NPI record certified
- 2026-01-13
This is when the NPI record was last certified, not a medical board exam.